α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls
about
Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interferenceAutoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Alpha-synuclein levels in blood plasma decline with healthy aging.Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein.Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.Alpha-Synuclein as a Biomarker for Parkinson's Disease.Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease.A sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples.Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls.Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson's Disease.A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
P2860
Q28545821-468F4B57-5F68-4585-A408-6ECC8CA86F14Q33776552-E5778096-035D-4077-8C15-A648367F997BQ34627859-BBEA7C5A-37DF-4303-A914-0A0B58019817Q34760606-528D1584-BB45-4746-AA5D-DAA7D55C1CB7Q35139572-32A0820D-9B6D-4115-9369-E6C9FFD84D76Q35284843-14B0B041-907D-45BA-84B2-DC6BC0A1BD57Q36894433-3DA32DAC-8437-4232-9BC9-BC79D7C3E433Q37024615-E99EA4C7-A1A2-49BB-959D-8A661306AFD3Q37274056-F5F7FA20-C9F3-4DDC-AB1D-5A27BE175BE0Q38184645-D10EAF22-4C8F-42DA-9D1C-24E1FA54B310Q38759482-2C1D9523-FC29-4B2F-A6AE-F3EE13BD3A2AQ41000187-2076877D-EABD-45F9-AC42-35B54303F9E9Q42190840-326BCB1E-F256-446F-B251-4C0B9E88E462Q42735183-CC925304-6447-40E2-B991-363786AE59D7Q50117645-FBDD0DA4-6828-46D1-8027-6E496BB4156BQ58592665-2125F216-95F1-4101-A75F-00CEAF1386A7
P2860
α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@ast
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@en
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@nl
type
label
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@ast
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@en
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@nl
prefLabel
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@ast
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@en
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@nl
P2093
P2860
P921
P1433
P1476
α-Synuclein and anti-α-synucle ...... disorder, and healthy controls
@en
P2093
Andrea C Klaver
David A Loeffler
Lynnae M Smith
Mary P Coffey
Mya C Schiess
P2860
P304
P356
10.1371/JOURNAL.PONE.0052285
P407
P577
2012-12-17T00:00:00Z